Dumont, J.M
The safety profile was consistent with GLP-1 receptor agonists, with gastrointestinal events including nausea, vomiting, diarrhea, constipation, or abdominal pain, being most common (affecting 79.6% in the cagrilintidesemaglutide group and 39.9% in the placebo group) but mainly transient and mild to moderate in severity
Animal data is more robust
Melanotan II 10mg Melanotan II is a synthetic analog of the naturally occurring melanocortin peptide hormone alpha-melanocyte-stimulating hormone (-MSH).
Weight Loss Trajectories and Short-Term Prediction in an Online Weight Management Program
Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, et al